Eckert & Ziegler SE
XETRA:EUZ
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Eckert & Ziegler SE
XETRA:EUZ
|
DE |
|
F
|
Fresnillo PLC
F:FNL
|
MX |
|
B
|
Briacell Therapeutics Corp
TSX:BCT
|
CA |
|
Aethlon Medical Inc
NASDAQ:AEMD
|
US |
|
Seven & i Holdings Co Ltd
F:S6MA
|
JP |
|
H
|
Hotel101 Global Holdings Corp
NASDAQ:HBNB
|
SG |
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is EUZ's stock price target?
Price Target
21.42
EUR
According to Wall Street analysts, the average 1-year price target for EUZ is 21.42 EUR with a low forecast of 20.5 EUR and a high forecast of 24.15 EUR.
What is the Revenue forecast for Eckert & Ziegler SE?
Projected CAGR
7%
Over the last 13 years, the compound annual growth rate for Revenue has been 8%. The projected CAGR for the next 3 years is 7%.
What is the Gross Profit forecast for Eckert & Ziegler SE?
Projected CAGR
8%
Over the last 13 years, the compound annual growth rate for Gross Profit has been 7%. The projected CAGR for the next 3 years is 8%.
What is the Operating Income forecast for Eckert & Ziegler SE?
Projected CAGR
8%
Over the last 13 years, the compound annual growth rate for Operating Income has been 11%. The projected CAGR for the next 3 years is 8%.
What is the Pre-Tax Income forecast for Eckert & Ziegler SE?
Projected CAGR
6%
Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been 12%. The projected CAGR for the next 3 years is 6%.
What is the Net Income forecast for Eckert & Ziegler SE?
Projected CAGR
8%
Over the last 13 years, the compound annual growth rate for Net Income has been 13%. The projected CAGR for the next 3 years is 8%.